Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb;74(2):484-485.
doi: 10.1016/j.jhep.2020.10.020. Epub 2020 Oct 29.

Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"

Dong Ji  1 , Gregory Cheng  2 , George Lau  3
Affiliations
Comment

Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"

Dong Ji et al. J Hepatol. 2021 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

References

    1. Mushtaq K., Khan M., Iqbal F., Alsoub D., Chaudhry H., Ata F. NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues. J Hepatol. 2021;74(2):482–484. - PMC - PubMed
    1. Ji D., Qin E., Xu J., Zhang D., Cheng G., Wang Y. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73(2):451–453. - PMC - PubMed
    1. Zhou Y.J., Zheng K.I., Wang X.B., Yan H.D., Sun Q.F., Pan K.H. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: a multicenter preliminary analysis. J Hepatol. 2020;73(3):719–721. - PMC - PubMed
    1. Lax S., Skok K., Zechner P., Kessler H., Kaufman F., Koelblinger C. Pulmonary arterial thrombosis in COVID-19 with fatal outcome:results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020;173(5):350–361. - PMC - PubMed
    1. Verrijken A., Francque S., Mertens I., Prawitt J., Caron S., Hubens G. Prothrombotic factors in histologically proven NAFLD and NASH. Hepatology. 2014;59:121–129. - PubMed